Short answer · Medically reviewed summary · Last updated: 2026-04-06
The prevalence of Addison Disease, or primary adrenal insufficiency, is estimated to be between 100 and 140 cases per million people in industrialized nations, though these figures often vary by region. Epidemiological Overview In terms of incidence, Addison Disease is diagnosed in approximately 5 to 6 new cases per million people annually. While this places the condition within the "rare disease" category, it remains one of the most significant endocrine disorders managed by specialists.
5 people with Addison Disease have shared their first-person experience on this question at DiseaseMaps.
The prevalence of Addison Disease, or primary adrenal insufficiency, is estimated to be between 100 and 140 cases per million people in industrialized nations, though these figures often vary by region.
In terms of incidence, Addison Disease is diagnosed in approximately 5 to 6 new cases per million people annually. While this places the condition within the "rare disease" category, it remains one of the most significant endocrine disorders managed by specialists. Because the early symptoms of Addison Disease—such as fatigue, weight loss, and mild hypotension—are non-specific, the condition is frequently underdiagnosed or misdiagnosed, suggesting that the true prevalence may be higher than current epidemiological data indicates.
Addison Disease typically manifests in adults between the ages of 30 and 50, though it can occur at any age, including during childhood. Regarding gender distribution, autoimmune Addison Disease is reported to affect females more frequently than males, often at a ratio of approximately 2:1. There is no strong evidence suggesting significant ethnic or geographic clustering for the autoimmune form of the disease, although the prevalence of specific underlying causes, such as tuberculosis-induced adrenal insufficiency, remains higher in developing regions.
Standard medical literature provides a foundational baseline for understanding the scope of Addison Disease, but clinical data cannot capture the full patient experience. Within the DiseaseMaps.org community, 1,592 people living with Addison Disease have actively shared their journeys. This real-world evidence provides invaluable insights into the diagnostic delays and the day-to-day management of the condition that are often missing from traditional clinical registries. By connecting with this community, patients and caregivers can find support that complements the clinical understanding of the disease's rarity and impact.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your endocrinologist or other qualified health provider with any questions you may have regarding a medical condition.